93 related articles for article (PubMed ID: 15767178)
1. A population survival model for breast cancer.
Stracci F; La Rosa F; Falsettini E; Ricci E; Aristei C; Bellezza G; Bolis GB; Fenocchio D; Gori S; Rulli A; Mastrandrea V
Breast; 2005 Apr; 14(2):94-102. PubMed ID: 15767178
[TBL] [Abstract][Full Text] [Related]
2. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
3. [Significance of medical data availability for the assessment of prognostic factors in cancer patients. Analysis based on a study of cervical cancer population].
Bielska-Lasota M
Przegl Epidemiol; 2005; 59(1):87-96. PubMed ID: 16013414
[TBL] [Abstract][Full Text] [Related]
4. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
5. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer.
Osborne C; Ostir GV; Du X; Peek MK; Goodwin JS
Breast Cancer Res Treat; 2005 Sep; 93(1):41-7. PubMed ID: 16184457
[TBL] [Abstract][Full Text] [Related]
6. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
7. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
8. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
9. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
Seppänen J; Heinävaara S; Holli K; Hakulinen T
Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.
Kroman N; Jensen MB; Wohlfahrt J; Ejlertsen B;
Acta Oncol; 2008; 47(4):545-9. PubMed ID: 18465320
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
14. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
15. Survival of male breast cancer patients: population-based cohort study.
Thalib L; Hall P
Cancer Sci; 2009 Feb; 100(2):292-5. PubMed ID: 19077006
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study.
Hartley MC; McKinley BP; Rogers EA; Kalbaugh CA; Messich HS; Blackhurst DW; Lokey JS; Trocha SD
Am Surg; 2006 Dec; 72(12):1189-94; discussion 1194-5. PubMed ID: 17216817
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.
Grabau D; Jensen MB; Rank F; Blichert-Toft M
APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850
[TBL] [Abstract][Full Text] [Related]
18. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
Chen SL; Hoehne FM; Giuliano AE
Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
[TBL] [Abstract][Full Text] [Related]
20. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
Evans AJ; Rakha EA; Pinder SE; Green AR; Paish C; Ellis IO
J Med Screen; 2007; 14(4):210-4. PubMed ID: 18078567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]